AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impact of a Physical Activity Program to Reduce Long-term Cancer-related Fatigue in Metastatic Testicular Germ Cell Tumor Patients

RecruitingNAAges 18 Years - anyMaleCentre Leon Berard
💬

In plain words

What the trial is, and whether it could suit you

Testicular germ cell tumor (TGCT) is the most common malignancy in men between 15 and 40 years. Although TCGT survivors have a good survival prognosis, they suffer from short- and long-term sequelae such as chronic fatigue, psychological disorders, cardiovascular toxicities and second malignancies. The benefits of physical activity (PA) during treatments have been demonstrated in cancer patients to improve quality of life (QoL) and physical fitness and to reduce fatigue. However, few PA programs have been proposed to TGCT patients and their effects on sequelae have not been assessed yet. A growing body of evidence links treatment-related alteration in the gut microbiota to sequelae of cancer survivors, including fatigue and cardiovascular toxicities. Also, PA has been known as a possible modulator of the gut microbiota composition. To date, no study has been conducted to examine how the

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Men ≥18 years * With a metastatic germ cell tumor histologically confirmed (seminoma and non-seminoma) * Who have already undergone an orchidectomy (since the 16th december, this criteria was deleted). * Having a first line of chemotherapy planned with BEP, EP or VIP * Having a smartphone (i.e. to connect the activity tracker) * PS \< or = 2 * Whose ability to practice an adapted physical activity (APA) has been certified by a medical certificate issued by the referring oncologist or the investigating physician * Available and willing to participate in the study for the duration of the intervention and follow-up, * Able to understand, read and write French, * Affiliated with a social security scheme, * Having dated and signed an informed consent. Exclusion Criteria: * Presence of symptomatic bone and/or brain metastases * Central nervous system involvement with neurological deficits preventing walking * History or coexistence of another primary cancer (apart from in situ cancer of any location and/or basal cell skin cancer and/or basal cell skin cancer and/or a cancer in complete remission for more than 3 years), * Contraindication to physical activity (e.g. uncontrolled hypertension, uncontrolled heart disease) uncontrolled heart disease), * Unable to be followed for medical, social, family, geographical or psychological reasons, during the entire study period, * Deprived of liberty by judicial or administrative decision, or adults protected by law, * Concurrent participation in another study in PA.
💊

What it tests

  • Physical activity recommendations
  • Connected activity tracker
  • Physical Activity (PA) Intervention
📍

Where

12 sites
Institut de Cancérologie de Lorraine
Angers, France
CHU Jean Minjoz
Besançon, France
Institut Bergonié
Bordeaux, France
Centre François Baclesse
Caen, France
Centre Oscar Lambret
Lille, France
Centre Leon Berard
Lyon, France
Institut de Cancérologie de Lorraine
Nancy, France
Centre Antoine Lacassagne
Nice, France

…and 4 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy